But that total money at the current exchange rate is only 6.3 million US$ Was that new shares or available shares on MSB?
That certainly wouldn't add to monies for trials, but I am not sure what you are suggesting.
I was going to write that being a Yank, I have hoped that by now there would be an active listing here on an American exchange. I currently own thru the ASX and the International Desk of Fidelity. But knowing that it would be actually listed on an American exchange, I think that there would be more shareholders. I will add with caution, however, Paradigm and Zilosul are still a major unknown in the States by the general public. How many Biopharma's know is anyone's guess. I think that their interests still lie on the back burner at this point, waiting for more proof of it's abilities.
AND, I am more convinced than ever that come the fall, 3rd quarter this year, the forecast calls for pain economically. There is not a whole lot of Media coverage of all the Commercial, mortgage, car loans defaulting, purchases at Big Box stores down, Warehouses half empty, and they are not having free returns on many things, US Postal shipping and mail down, Tighter financing....all the things that came around last 2005-06 causing 2008 have been ignored and amplified thru cheap credit over the years. Credit card rates at over 20%. Car sales down. I could go on, and I wonder how things are going in Australia? I can't imagine big pharma jumping on a company still in trials for millions/billions makes sense at this point.
Sorry for the rant, but this is may be the only reason I can think of that PAR and lots of other fine companies are having their stock prices drawn down to ridiculous levels, all while everything else in the world seems to be going up in price. There, I almost feel better for getting that out of my system.
- Forums
- ASX - By Stock
- PAR
- Funding options
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
4.76%
!
44.0¢

Funding options, page-15
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
44.0¢ |
Change
0.020(4.76%) |
Mkt cap ! $174.8M |
Open | High | Low | Value | Volume |
42.5¢ | 46.0¢ | 42.0¢ | $347.2K | 796.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16968 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.5¢ | 2449 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16968 | 0.440 |
1 | 10000 | 0.435 |
3 | 17957 | 0.430 |
2 | 82297 | 0.420 |
3 | 40881 | 0.415 |
Price($) | Vol. | No. |
---|---|---|
0.455 | 2449 | 1 |
0.460 | 29978 | 2 |
0.465 | 112360 | 2 |
0.470 | 87163 | 5 |
0.475 | 46456 | 2 |
Last trade - 16.10pm 15/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online